These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21438740)

  • 1. Existing and emerging therapies for irritable bowel syndrome.
    Acosta RD; Cash BD
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):389-402. PubMed ID: 21438740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of irritable bowel syndrome and an update on therapeutic approaches.
    Bassett JT; Cash BD
    Expert Opin Pharmacother; 2008 May; 9(7):1129-43. PubMed ID: 18422471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: The treatment of irritable bowel syndrome.
    Lesbros-Pantoflickova D; Michetti P; Fried M; Beglinger C; Blum AL
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1253-69. PubMed ID: 15606387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigational agents for the irritable bowel syndrome.
    Ghaith O; El-Halabi M; Hashash JG; Sharara AI
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1161-78. PubMed ID: 20836617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current medical treatments of dyspepsia and irritable bowel syndrome.
    Camilleri M; Tack JF
    Gastroenterol Clin North Am; 2010 Sep; 39(3):481-93. PubMed ID: 20951913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs for irritable bowel syndrome.
    Treat Guidel Med Lett; 2011 Jul; 9(107):41-6. PubMed ID: 21701443
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.
    Ponziani FR; Pecere S; Lopetuso L; Scaldaferri F; Cammarota G; Gasbarrini A
    Expert Opin Drug Saf; 2016 Jul; 15(7):983-91. PubMed ID: 27149541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment.
    Chang JY; Talley NJ
    Trends Pharmacol Sci; 2010 Jul; 31(7):326-34. PubMed ID: 20554042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.
    Camilleri M
    Expert Opin Pharmacother; 2013 Jun; 14(9):1151-60. PubMed ID: 23621801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome.
    Frissora CL; Cash BD
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1271-81. PubMed ID: 17509095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options in irritable bowel syndrome.
    Farthing MJ
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners.
    Grundmann O; Yoon SL
    J Gastroenterol Hepatol; 2010 Apr; 25(4):691-9. PubMed ID: 20074154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Irritable bowel syndrome].
    Musch A
    Med Monatsschr Pharm; 2006 Oct; 29(10):378-9. PubMed ID: 17058897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Serotonin 5- HT4 receptor agonist (mosapride citrate)].
    Odaka T; Suzuki T; Seza A; Yamaguchi T; Saisho H
    Nihon Rinsho; 2006 Aug; 64(8):1491-4. PubMed ID: 16898619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.
    Piovezani Ramos G; Camilleri M
    Dig Dis Sci; 2023 May; 68(5):1677-1690. PubMed ID: 36376576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
    Johanson JF
    Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.